Xuejiao Zhao

Wuhan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The DAPK3-DCAF1 pathway regulates ZBP1 protein stability to orchestrate PANoptosis for ovarian cancer therapy.

The DAPK3-DCAF1 pathway regulates ZBP1 protein stability to orchestrate PANoptosis for ovarian cancer therapy.

Journal: Journal of hematology & oncology

Published: March 04, 2026

ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer.

ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: October 20, 2025

Sequential treatment with PARPi and WEE1i enhances antitumor immune responses in preclinical models of ovarian cancer.

Sequential treatment with PARPi and WEE1i enhances antitumor immune responses in preclinical models of ovarian cancer.

Journal: Science translational medicine

Published: August 13, 2025

Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy.

Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy.

Journal: Science translational medicine

Published: May 07, 2025

Identifying therapeutic strategies for triple-negative breast cancer via phosphoproteomics.

Identifying therapeutic strategies for triple-negative breast cancer via phosphoproteomics.

Journal: Expert review of proteomics

Published: November 26, 2024

Rictor orchestrates β-catenin/FOXO balance by maintaining redox homeostasis during development of ovarian cancer.

Rictor orchestrates β-catenin/FOXO balance by maintaining redox homeostasis during development of ovarian cancer.

Journal: Oncogene

Published: November 15, 2024

Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis.

Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis.

Journal: Journal of ovarian research

Published: October 26, 2021

Correction to: FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer.

Correction to: FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 17, 2019

FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer.

FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 12, 2017

Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells.

Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells.

Journal: Autophagy

Published: April 21, 2015

Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance.

Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance.

Journal: Biochemical and biophysical research communications

Published: February 16, 2015

PP242 synergizes with suberoylanilide hydroxamic acid to inhibit growth of ovarian cancer cells.

PP242 synergizes with suberoylanilide hydroxamic acid to inhibit growth of ovarian cancer cells.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: September 05, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026